Suppr超能文献

纤溶酶产生的人纤维蛋白原高分子量衍生物(片段X)的抗凝和钙结合特性

Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen, produced by plasmin (fragments X).

作者信息

Nieuwenhuizen W, Gravesen M

出版信息

Biochim Biophys Acta. 1981 Mar 27;668(1):81-8. doi: 10.1016/0005-2795(81)90151-3.

Abstract

Early plasmin degradation products (X fragments) of human fibrinogen were prepared in the presence of calcium-ions or EGTA, and purified on Sepharose 6B-CL. X fragments were characterized with respect to amino-terminal amino acids, polypeptide-chain composition, anticlotting properties and calcium-binding. Amino-terminal amino acids were alanine and tyrosine. The molecular weights of the chains were about 26 000, 58 000 and 48 000 for A alpha-, B beta- and gamma-chains, respectively. X fragments were about 6-times as potent in anticlotting behaviour as D fragments prepared in the presence of calcium ions. Calcium-binding properties were essentially identical to those of fibrinogen. No differences were observed between X fragments prepared in the presence of calcium ions and those prepared in the presence of EGTA. This indicates that the carboxy-terminal parts of the A alpha-chains of fibrinogen are not involved in calcium-binding and that differences in chain-remnants as observed in late plasmic degradation products (which depend on the presence of calcium ions or EGTA [23] in the incubation medium) are introduced beyond the stage of fragment X formation.

摘要

人纤维蛋白原的早期纤溶酶降解产物(X片段)在钙离子或乙二醇双四乙酸(EGTA)存在的情况下制备,并在交联琼脂糖凝胶6B-CL上进行纯化。对X片段的氨基末端氨基酸、多肽链组成、抗凝血特性和钙结合情况进行了表征。氨基末端氨基酸为丙氨酸和酪氨酸。Aα链、Bβ链和γ链的分子量分别约为26000、58000和48000。X片段的抗凝血活性约为在钙离子存在下制备的D片段的6倍。钙结合特性与纤维蛋白原基本相同。在钙离子存在下制备的X片段与在EGTA存在下制备的X片段之间未观察到差异。这表明纤维蛋白原Aα链的羧基末端部分不参与钙结合,并且在晚期纤溶降解产物中观察到的链残余差异(这取决于孵育介质中钙离子或EGTA的存在[23])是在片段X形成阶段之后引入的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验